Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.
about
Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice.ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.A hypothesis of couplet molecules and couplet cells in gastric function and an association with Helicobacter pylori.Regulation and roles of bicarbonate transporters in cancer.Bicarbonate transport in health and disease.High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.Krüppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma.EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells.Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma.Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling.Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma.
P2860
Q35349177-F543BB45-075E-432B-A699-9EE2266B0479Q35581875-BEB5B7EE-6408-4B42-89B0-8D5CD4E7BA04Q35924426-9A7DCA73-41DA-45D8-9BE7-42040E482BE3Q37719006-8686EC15-736D-403C-AE57-D523959E3F9BQ38255748-DDF5BB78-1AA6-4216-8C83-C5B84A20B4E5Q38724794-09EC1003-DA5A-43FF-80AA-A0127B630479Q38756655-2E9E0EDB-A1EC-414B-8FDF-89321F62F005Q38853156-6CC42A35-1F78-4A1A-8697-D6DA1DF68FD1Q39042827-8AFA1B5E-B4AF-482F-A558-39B84AB79E20Q39250374-55FC556C-2C10-44F8-A436-DB93AA262F9EQ41123353-539A95FC-695C-4D6B-980C-266E810E1DFCQ41813458-C9C77ACA-3C00-48F7-9B98-2FDBC2BA6DE9Q45190761-86007CDF-29CC-498B-B13D-848D5B68D3DEQ55022497-F05E2A66-14E3-4C4A-83B1-5F811CDD8DE8
P2860
Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@en
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@nl
type
label
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@en
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@nl
prefLabel
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@en
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@nl
P2093
P2860
P1476
Gastrin inhibits a novel, path ...... nvolving EGR1, AE2, and P-ERK.
@en
P2093
Guo-Hui Fu
Heng-Jing Cui
Ling-Jun Song
Rui-Jun Liu
Seth L Alper
Zhao-Wen Yan
P2860
P2888
P304
P356
10.1007/S00109-011-0851-2
P577
2012-01-07T00:00:00Z